RT @JonathanRyderMD: @DxRxEdu Thanks for sharing. Two interesting ERCP/cholangitis topics: Rectal indomethacin decreases risk of post-ER…
@DxRxEdu Thanks for sharing. Two interesting ERCP/cholangitis topics: Rectal indomethacin decreases risk of post-ERCP pancreatitis in RCT: https://t.co/5lDAwvdfjc Short course (4 days) antibiotics non-inferior to longer in cholangitis in RCT https://t.
@spcanelon @riannone @thomas_mock I built this one entirely in ggplot: https://t.co/1l90fXPLHq (figure 4). If it would be helpful, I can dig out the code (and data formatting -which was key) later this week.
RT @TylerLarsenMD: Inpatient Pearl Day 1/14: Rectal Indomethacin may be helpful in reducing incidence of post-ERCP pancreatitis. https://t…
RT @TylerLarsenMD: Inpatient Pearl Day 1/14: Rectal Indomethacin may be helpful in reducing incidence of post-ERCP pancreatitis. https://t…
Inpatient Pearl Day 1/14: Rectal Indomethacin may be helpful in reducing incidence of post-ERCP pancreatitis. https://t.co/JRfp3a98Ac
#pancreatitis @NorthwesternMed @NUFeinbergMed @NU_IntMed
RT @MelBreggs: Inpatient Day 13: Rectal Indomethacin given during ERCP statistically decreases post-ERCP pancreatitis in high-risk patients…
RT @MelBreggs: Inpatient Day 13: Rectal Indomethacin given during ERCP statistically decreases post-ERCP pancreatitis in high-risk patients…
RT @MelBreggs: Inpatient Day 13: Rectal Indomethacin given during ERCP statistically decreases post-ERCP pancreatitis in high-risk patients…
RT @MelBreggs: Inpatient Day 13: Rectal Indomethacin given during ERCP statistically decreases post-ERCP pancreatitis in high-risk patients…
Inpatient Day 13: Rectal Indomethacin given during ERCP statistically decreases post-ERCP pancreatitis in high-risk patients. A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis | NEJM https://t.co/v7JmcxBEV9
RT @rvawellmd: Just one of many evidenced-based learning points from a fantastic @VCU_IMRes GI core conference @chrisLyoungmd @DrJared…
Just one of many evidenced-based learning points from a fantastic @VCU_IMRes GI core conference @chrisLyoungmd @DrJaredDyer Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis | NEJM https://t.co/8v24L809L6
@tony_breu @ebtapper @GI_Pearls Given the evidence for indomethacin for prevention, an indomethacin for treatment trial seems warranted. https://t.co/1l90fXPLHq
In 2012, B.J. Elmunzer published study showing indomethacin PR could reduce pancreatitis after an invasive diagnostic procedure (ERCP) by ~50%. Great! An LoCost med (~$15 at the time) could prevent > 5k cases of pancreatitis (a bad complication) a yr. /
RT @RebeccaEBerger: Inpatient day 1/14 pearl @WeillCornell - patients at high risk of post-ERCP pancreatitis randomized to received indomet…
Inpatient day 1/14 pearl @WeillCornell - patients at high risk of post-ERCP pancreatitis randomized to received indomethacin had lower risk of pancreatitis compared to placebo - high risk included sphincterotomy, multiple cannulation attempts, etc https://
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @ProfHayward: This is the type of market failure that needs to be closed. A new study shows a old inexpensive med has great value. Singl…
RT @bnallamo: Wow, @JElmunzer... Sad to see price gouging of generics not restrained to cardiology & oncology... @UmeshKhotMD @DavidLBro…
Wow, @JElmunzer... Sad to see price gouging of generics not restrained to cardiology & oncology... @UmeshKhotMD @DavidLBrownMD @venkmurthy @VinayPrasadMD @JeremySussman https://t.co/Ve2Sems5VQ
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @ProfHayward: This is the type of market failure that needs to be closed. A new study shows a old inexpensive med has great value. Singl…
RT @ProfHayward: This is the type of market failure that needs to be closed. A new study shows a old inexpensive med has great value. Singl…
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
RT @JElmunzer: Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can…
This is the type of market failure that needs to be closed. A new study shows a old inexpensive med has great value. Single generic drug manufacturer jacks up price 15x, no1 rushes to enter market because profits will disappear w/ competition. No arg for a
Rectal NSAIDs for preventing post-ERCP pancreatitis: <$10/dose at end of trial (https://t.co/scaPU4CoYz), now >$150. How can we fix this @IrokoUSA & G&W laboratories? #drugpricing https://t.co/0998a2SPEy
RT @mlangston11: WOW. This thread. @walidgellad makes very adept comments from a clinician standpoint on #drugprices and economist @C_Garth…
RT @mlangston11: WOW. This thread. @walidgellad makes very adept comments from a clinician standpoint on #drugprices and economist @C_Garth…
RT @mlangston11: WOW. This thread. @walidgellad makes very adept comments from a clinician standpoint on #drugprices and economist @C_Garth…
WOW. This thread. @walidgellad makes very adept comments from a clinician standpoint on #drugprices and economist @C_Garthwaite tells him to get a degree in economics “before making statements on drug prices”. Clinicians worry about #drugprices b/c we worr
RT @matthewherper: Great question, example. https://t.co/0IkWnuSsR8
RT @ProfHayward: OK PharmEcon twitter @contirena1 @C_Garthwaite @amitabhchandra2 What is your solution to the following? Abt 6 yrs ago I…
My thoughts: 1) did the manufacturer sponsor the rct? 2) were you & faculty paid for your “help”? info about rx clinical utility can be used to justify inc prices in consumer products. This info tends to be industry sponsored. Academic faculty face i
RT @ProfHayward: OK PharmEcon twitter @contirena1 @C_Garthwaite @amitabhchandra2 What is your solution to the following? Abt 6 yrs ago I…
RT @matthewherper: Great question, example. https://t.co/0IkWnuSsR8
Great question, example. https://t.co/0IkWnuSsR8
Who paid for the rct? https://t.co/uK0IGkhDti
OK PharmEcon twitter @contirena1 @C_Garthwaite @amitabhchandra2 What is your solution to the following? Abt 6 yrs ago I helped a jr faculty member w/ an RCT that showed a cheap Rx (~$15) could decrease a major post-procedural complication by ~50% https:
@DeMadaria @lamv50 @AmCollegeGastro Indomethacin was not consumed by any patients in this trial https://t.co/6K9cZZgma0 and no GI bleeding or renal failure occurred.
@sarizabeth great for preventing post-ERCP pancreatitis. https://t.co/6K9cZZgma0
Rectal indomethacin (100mg) after ERCP in high-risk patients reduces risk of post-ERCP #pancreatitis: http://t.co/MXA2YoyKv2 (NEJM 2012)
......just finished discussing pancreatitis prophylaxis with indomethacin after ERCP in AM fellow conference http://t.co/sPK5VpXYfr
......just finished discussing pancreatitis prophylaxis with indomethacin after ERCP in AM fellow conference http://t.co/sPK5VpXYfr
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis — NEJM http://t.co/j0OJgx7KRp
PR Indomethacin for prevention of postERCP pancreatitis. Good study in @NEJM http://t.co/BQy9YxUC
Rectal Indomethacin to Prevent Post-ERCP Pancreatitis..http://www.nejm.org/doi/full/10.1056/NEJMoa1111103?query=gastroenterology
rectal indomethacin prevents post-ercp pancreatitis: http://t.co/OsYJLHVK
こんなに簡単な処置でリスク低下できるとは画期的だ。リクツはよくわからんけど。そもそもこの膵炎の原因もよくわからんのだけど。膵管造影検査後の膵炎をインドメタシンで発生抑制。 http://t.co/Rs8XFHCk
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. http://t.co/PA7D2mf5 #medicine
Prevention of ERCP pancreatitis http://t.co/xg5Sav5K #health #medicine
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. http://t.co/Ud2O8f6k #health
RT @geri_doc: Pancreatitis dreaded complication of ERCP. #NEJM study shows indomethacin (cheap!) reduces risk. Wow. http://t.co/DLTFcABy
RT @geri_doc: Pancreatitis dreaded complication of ERCP. #NEJM study shows indomethacin (cheap!) reduces risk. Wow. http://t.co/DLTFcABy
Pancreatitis dreaded complication of ERCP. #NEJM study shows indomethacin (cheap!) reduces risk. Wow. http://t.co/DLTFcABy
内視鏡的逆行性胆管膵管造影(ERCP)後膵炎の高リスク患者、ERCP直後のインドメタシン単回直腸内投与の膵炎予防効果を検証。膵炎の発症はインドメタシン群で9.2%、プラセボ群で16.9%、中等-重度膵炎の発症は4.4%、8.8%。http://t.co/KpLvy3ce
http://t.co/MPJLTMUo #RCT Rectal Indomethacin among patients at high risk significantly reduced incidence #Pancreatitis
Good news for anxious gastroenterologists: more evidence for NSAIDs in preventing pancreatitis after high-risk ERCP http://t.co/KCEAqPds
RT @Skepticscalpel: NEJM: Rectal indomethacin can prevent post-ERCP pancreatitis http://t.co/mQAacP5l
Indomethacin prevents post-ERCP pancreatitis- the new standard of care in high risk patients? http://t.co/OEDbMYW4
NEJM: Rectal indomethacin can prevent post-ERCP pancreatitis http://t.co/mQAacP5l
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis http://t.co/EY9Yr278 #pharmacy #health
インドメタシン座薬がERCP後の膵炎予防に有効な可能性(NEJM) http://t.co/FGP1P9pT :腎機能が悪かったり胃潰瘍のある人でなければ使うと良いかも。安い薬だし。
Rectal Indomethacin to Prevent Post-ERCP Pancreatitis- http://t.co/KkmWz6Em - very interesting.
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis | good for a journal club http://t.co/Psf96CLX
NEJM: Among patients at high risk for post-ERCP pancreatitis, rectal indomethacin signif reduced condition’s incidence. http://t.co/Blpkq8gY
a study w huge potential impact for patients “@NEJM: rectal indomethacin signif reduced post-ERCP pancreatitis. http://t.co/2Q4sRkxA”
“@NEJM:Among patients at high risk for post-ERCPpancreatitis,rectal indomethacin signif reduced condition’s incidence. http://t.co/ofZynGBg”
Esto hay que revisarlo bien @DrCasals @veryhappymc @MJCasanovaG #laprincesatop7 http://t.co/jZOIUFwg
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis — NEJM: http://t.co/LkJu8vB8
Among patients at high risk for post-ERCP pancreatitis, rectal indomethacin signif reduced condition’s incidence. http://t.co/R5pNvXjc